157 related articles for article (PubMed ID: 15038691)
1. Assessing patient satisfaction with desloratadine after conversion from loratadine, fexofenadine, or cetirizine.
Glass D; Harper A
Manag Care Interface; 2004 Feb; 17(2):29-34. PubMed ID: 15038691
[TBL] [Abstract][Full Text] [Related]
2. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
Glass DJ; Harper AS
BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
[TBL] [Abstract][Full Text] [Related]
3. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
4. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis.
Lee J; Cummins G; Okamoto L
Am J Manag Care; 2001 May; 7(4 Suppl):S103-12. PubMed ID: 11392821
[TBL] [Abstract][Full Text] [Related]
5. The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis.
Liao E; Leahy M; Cummins G
Am J Manag Care; 2001 Oct; 7(15 Suppl):S459-68. PubMed ID: 11680261
[TBL] [Abstract][Full Text] [Related]
6. Onset of action for the relief of allergic rhinitis symptoms with second-generation antihistamines.
Greisner WA
Allergy Asthma Proc; 2004; 25(2):81-3. PubMed ID: 15176489
[TBL] [Abstract][Full Text] [Related]
7. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.
Day JH; Briscoe MP; Clark RH; Ellis AK; Gervais P
Ann Allergy Asthma Immunol; 1997 Aug; 79(2):163-72. PubMed ID: 9291422
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
Prenner BM; Capano D; Harris AG
Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
[TBL] [Abstract][Full Text] [Related]
10. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
Roongapinun S; Wajajamreon S; Fooanant S
J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
[TBL] [Abstract][Full Text] [Related]
12. H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?
Church MK; Maurer M
Clin Exp Allergy; 2012 Oct; 42(10):1423-9. PubMed ID: 22994340
[TBL] [Abstract][Full Text] [Related]
13. [Clinical aspects of anti-inflammatory action of antihistamines].
Grzelewska-Rzymowska I
Pol Merkur Lekarski; 2003 Jun; 14(84):634-8. PubMed ID: 14524290
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.
Spangler DL; Brunton S
South Med J; 2006 Jun; 99(6):593-9. PubMed ID: 16800414
[TBL] [Abstract][Full Text] [Related]
15. Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs.
Benedetto SR; Sloan AS; Duncan BS
Am J Health Syst Pharm; 2000 Oct; 57(19):1778-85. PubMed ID: 11030030
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
17. Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
Mandhane SN; Shah JH; Bahekar PC; Mehetre SV; Pawar CA; Bagad AS; Chidrewar GU; Rao CT; Rajamannar T
Int Arch Allergy Immunol; 2010; 151(1):56-69. PubMed ID: 19672097
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
Meltzer EO; Gillman SA
Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
Kruszewski J; Kłos K; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
